wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26751214-1B794F9A-5A97-4B97-8264-DDA215F6C76B
Q26751214-1B794F9A-5A97-4B97-8264-DDA215F6C76B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26751214-1B794F9A-5A97-4B97-8264-DDA215F6C76B
Recent advances in the management of Hodgkin lymphoma
P2860
Q26751214-1B794F9A-5A97-4B97-8264-DDA215F6C76B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26751214-1B794F9A-5A97-4B97-8264-DDA215F6C76B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c46000a8db924a0cb51057864b0c8ac8759099c6
P2860
90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphoma